AstraZeneca’s Imfinzi (durvalumab) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Produc ...

12, 2024 — Researchers examined the impact of obesity in relation to treatment and mortality from data on over 500,000 lung cancer patients. This study suggests that immunotherapy may not be the ...

Ryan D’Souza, an anesthesiologist with the Mayo Clinic in Rochester, Minn. Platinum-based or taxane chemotherapy drugs appear ...

Doctors have used chemotherapy (chemo) to treat cancer since the 1940s. The advantage of these drugs is they kill cancer cells throughout your body. One downside is the side effects they can ...

Lung cancer survival without treatment is shorter than survival with treatment. People with untreated non-small cell lung cancer—the most common type—typically live between five and 12 months after ...

For example, it's common to have both liver metastases and brain metastases. What is the life expectancy for someone with lung cancer that has spread to the liver? With treatment, the life expectancy ...

Chemotherapy uses anti cancer drugs to destroy cancer cells. Sometimes doctors use the word cytotoxic to describe the way chemotherapy works. Cytotoxic means toxic to cells. Some people may have ...

AstraZeneca’s Tagrisso can be used alongside chemotherapy as a frontline therapy for EGFR-positive non-small cell lung cancer (NSCLC), according to the FDA, consolidating its position as the ...

AZ presented the results of the FLAURA-2 trial at the World Congress on Lung Cancer (WCLC) congress last month, showing that adding chemo to Tagrisso resulted in a 38% improvement in PFS compared ...

“Off-label treatment” refers to the prescription of pharmaceutical drugs outside their intended use. Gemcitabine disrupts DNA formation and slows or stops the growth of cancer cells. It is used to ...

SINGAPORE – A combination of two existing chemotherapy ... or stops the growth of cancer cells. It is used to treat testicular, breast, ovarian, non-small cell lung and pancreatic cancers.